Xcout Intel
SOMALOGIC, INC
SomaLogic, Inc. is an active biotechnology company headquartered in Boulder, Colorado, specializing in proteomics technology and biomarker discovery.
Subscribe to see SOMALOGIC, INC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
SOMALOGIC, INC at a glance
SOMALOGIC, INC is a biotechnology company headquartered in United States. Its most recent funding round raised $103M in November 2020.
SOMALOGIC, INC funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $103M | — | |
| Series A | $212M | 2 named | |
| SEC Form D filing | $969 | — | |
| SEC Form D filing | $44.9M | — | |
| SEC Form D filing | $163M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent SOMALOGIC, INC news
Investors
SOMALOGIC, INC competitors
A few of SOMALOGIC, INC's closest competitors — see the full list of competitors and alternatives →
Olink Proteomics provides high-throughput protein biomarker analysis products, instruments, software, and analysis services for life science research and drug development. Utilizing its proprietary Proximity Extension Assay (PEA) technology and next-generation sequencing, the company serves researchers and pharmaceutical organizations focused on biomarker discovery and precision medicine.
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
Impact Proteomics provides a proprietary antigen profiling and protein identification platform that analyzes patient samples to map disease-associated antigens without cloned intermediates. The company serves biotechnology and diagnostic partners by enabling target discovery, companion diagnostics development, and therapeutic selection for oncology and autoimmune diseases.
Adaptive Biotechnologies Corp. is a biotechnology company headquartered in Seattle, Washington, United States. The firm focuses on decoding and analyzing the human immune system to address various diseases.
Harmonigenic Corp. is a diagnostics and biotechnology company headquartered in Rochester, New York. The company brings radical innovation to personalized precision medicine, focusing on initial diagnostic and treatment decisions.
OncoHost is an Israeli precision-oncology biotechnology company that develops blood-based proteomic tests and computational analytics to characterize cancer patients and predict responses to immunotherapy. Its products are intended to help oncologists personalize treatment decisions and identify mechanisms of resistance, serving cancer patients, clinicians, pharmaceutical companies, and researchers.
Get SOMALOGIC, INC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on SOMALOGIC, INC in Xcout Intel
- 5 funding rounds with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access